SLNO - Company ID 0001484565
SOLENO THERAPEUTICS INC (SLNO) reported net income of $20.89M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $20.89M | +111.9% |
| FY 2024 | -$175.85M | -351.0% |
| FY 2023 | -$38.99M | -62.0% |
| FY 2022 | -$24.07M | +22.1% |
| FY 2021 | -$30.91M | -25.5% |
| FY 2020 | -$24.64M | +19.9% |
| FY 2019 | -$30.77M | -130.8% |
| FY 2018 | -$13.34M | +13.3% |
| FY 2017 |
SOLENO THERAPEUTICS INC (SLNO) reported net income of $20.89M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2025, SOLENO THERAPEUTICS INC's net income grew from -$3.71M to $20.89M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$15.38M |
| -27.5% |
| FY 2016 | -$12.07M | +24.2% |
| FY 2015 | -$15.91M | -20.2% |
| FY 2014 | -$13.24M | -257.1% |
| FY 2013 | -$3.71M | - |